NCT05970796

A Telehealth-delivered Physical Therapy Program for Postmenopausal Women with Urinary Incontinence

Completed NA Last updated 14 November 2024

What this trial tests

NA trial testing Pelvic floor muscle training in Urinary Incontinence in 22 participants. Completed in 31 October 2024.

Timeline

1 December 2023

Primary endpoint
31 October 2024

31 October 2024

Quick facts

Lead sponsor	National Taiwan University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	22
Start date	1 December 2023
Primary completion	31 October 2024
Estimated completion	31 October 2024
Sites	1 location across Taiwan

Drugs / interventions tested

• Pelvic floor muscle training

Conditions studied

• Urinary Incontinence — all drugs for Urinary Incontinence →

Sponsor

National Taiwan University

Who can join

Adults 40 to 85, female only, with Urinary Incontinence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postmenopausal women frequently report physical (hot flushes, night sweat, insomnia, vaginal dryness, sexual dysfunction, urinary incontinence, reduced fitness level, osteoporotic symptoms, sarcopenia, decreased fat free mass, etc.) and psychological (depression, anxiety, cognitive decline, etc.) symptoms. Among these symptoms, urinary incontinence is one of the most common manifestations of pelvic floor dysfunction and may significantly impact on women's quality of life. Urinary incontinence is highly prevalent (30%) in postmenopausal women and is primarily attributed to the decreased level of estrogen. Other potential risk factors for urinary incontinence after menopause include age, parity, genetic factors, pregnancy, overweight/obesity, low physical activity levels, diabetes, urinary tract infection, etc. International guidelines recommend lifestyle and behavioral change, pelvic floor muscle training and bladder training as first-line treatments for urinary incontinence in postmenopausal women. During the COVID-19 pandemic, access to and utilization of healthcare services is reduced. As travel distance has been reported as one of the strong barriers to healthcare among patients with incontinence, research has been conducted to investigate the applications and effects of telehealth. While telehealth rehabilitation may improve urinary incontinence symptoms, the field is still emerging and more studies are needed to elucidate how physical therapists can perform telehealth pelvic floor muscle training for urinary incontinence.

The objectives of this three-year study are:

1. to investigate the feasibility of a telehealth-delivered physical therapy program for postmenopausal women with urinary incontinence
2. to explore the effects of a telehealth-delivered physical therapy program on urinary incontinence symptoms, pelvic floor muscle function and quality of life in postmenopausal women with urinary incontinence
3. to compare the effectiveness of telehealth physical therapy program with face-to-face physical therapy in this population
4. to compare body composition, physical activity levels, functional capacity, grip strength, urinary incontinence symptoms, and pelvic floor muscles function in women at early versus late stage of post-menopause
5. to evaluate the relationships between duration after menopause and body composition, physical activity levels, functional capacity, grip strength, urinary incontinence symptoms, and pelvic floor muscles function

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women.
   Hay-Smith EJC, Starzec-Proserpio M, Moller B, Aldabe D, et al · · 2024 · cited 7× · PMID 39704322 · DOI 10.1002/14651858.cd009508.pub2
2. The feasibility and effects of a telehealth-delivered physical therapy program for postmenopausal women with urinary incontinence: A pilot mixed-methods study.
   Lin KY, Chen CY, Wu PC, Huang MH, et al · · 2025 · cited 2× · PMID 40286562 · DOI 10.1016/j.maturitas.2025.108376